0001638599-19-000654.txt : 20190715
0001638599-19-000654.hdr.sgml : 20190715
20190715174639
ACCESSION NUMBER: 0001638599-19-000654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190711
FILED AS OF DATE: 20190715
DATE AS OF CHANGE: 20190715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaBelle Curt H
CENTRAL INDEX KEY: 0001396235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 19955896
MAIL ADDRESS:
STREET 1: C/O INVESTOR GROWTH CAPITAL, INC.
STREET 2: 630 FIFTH AVENUE, SUITE 1965
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
4
1
doc4_6180.xml
PRIMARY DOCUMENT
X0306
4
2019-07-11
0
0001682639
EYENOVIA, INC.
EYEN
0001396235
LaBelle Curt H
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
1
0
0
0
Common Stock, par value $.0001
2019-07-11
4
P
0
17985
2.78
A
27985
D
Common Stock, par value $.0001
606667
I
By Private Medical Equity, Inc.
Common Stock, par value $.0001
453333
I
By PME Investor Services Eyenovia, LLC
Stock Option (right to buy)
1.24
2015-03-02
2025-03-02
Common Stock
40000
40000
D
Stock Option (right to buy)
1.95
2027-07-07
Common Stock
133334
133334
D
Stock Option (right to buy)
1.24
2015-03-23
2025-03-23
Common Stock
140000
140000
I
By Private Medical Equity, Inc.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2019-07-15